Vitalhub Corp.
TSX:VHI.TOMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $421.84M
- Beta
- 0.77
- P/E (TTM)
- 62.1
- EPS (TTM)
- $0.12
Volume 0.23M
Average 0.41M
VHI.TO Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Vitalhub Corp.TSX: VHI.TO
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of CA$9.44M rose 123.2% year over year, ahead of the +109.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 5.1% from the prior quarter. Over 3 fiscal years it compounded at +66.5% a year.
Context
- Cost of revenue amounted to 29.8% of revenue in FY2025, up 10.7 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +123.2% holds above the trailing-twelve-month pace of +109.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
CAD · from the income statement
- Latest · FY2025
- 32.46M CAD
- Year-over-year change
- +147.8%
- 4-year CAGR
- +57.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.46M | +147.8% |
| FY2024 | 2024-12-31 | 13.1M | +35.1% |
| FY2023 | 2023-12-31 | 9.7M | +37.9% |
| FY2022 | 2022-12-31 | 7.03M | +34.3% |
| FY2021 | 2021-12-31 | 5.24M | — |
Cost of Revenue vs competitors
How VHI.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +109.3% is the 2nd highest of 7, against a peer median of +48.0%.
- Cost of revenue amounts to 25.2% of revenue for VHI.TO, versus a peer median of 55.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$319.93M CAD | +55.9% | +24.4% | 62.7% | |
| LTM Mar 2026 | CA$218.14M CAD | +40.1% | +0.7% | 68.5% | |
| LTM Mar 2026 | $128.47M USD | -10.2% | -13.4% | 49.1% | |
| LTM Mar 2026 | CA$30.05M CAD | +109.3% | +66.5% | 25.2% | |
| LTM Mar 2026 | CA$26.53M CAD | +101.5% | +46.4% | 39.9% | |
| LTM Mar 2026 | $12.97M USD | +17.0% | +63.9% | 25.5% | |
| LTM Mar 2026 | CA$4.95M CAD | +344.3% | +123.1% | 179.2% | |
| Peer median (excluding VHI.TO) | — | +48.0% | +35.4% | 55.9% | |
Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 24.66M | 39.97M | 52.51M | 68.59M | 108.97M |
| Cost of Revenue | 5.24M | 7.03M | 9.7M | 13.1M | 32.46M |
| Gross Profit | 19.43M | 32.94M | 42.81M | 55.49M | 76.51M |
| Gross Margin | 78.8% | 82.4% | 81.5% | 80.9% | 70.2% |
| Research & Development | 6.05M | 10.43M | 12.17M | 15.23M | 28.95M |
| Selling, General & Admin | 10.41M | 13.97M | 18.8M | 24.56M | 35.39M |
| Operating Expenses | 19.13M | 28.28M | 42.81M | 45.75M | 64.34M |
| Depreciation & Amortization | 2.68M | 3.87M | 4.98M | 5.96M | 11.08M |
| EBITDA | 1.12M | 5.25M | 10.38M | 11.9M | 23.25M |
| EBITDA Margin | 4.5% | 13.1% | 19.8% | 17.4% | 21.3% |
| Operating Income | 324.33K | 4.66M | 6.86M | 9.74M | 12.17M |
| Operating Margin | 1.3% | 11.7% | 13.1% | 14.2% | 11.2% |
| Interest Income | 29.55K | 0 | 489.57K | 1.95M | 2.42M |
| Interest Expense | 82.43K | 70.35K | 71.98K | 43.01K | 70.35K |
| Other Income / Expenses | (1.94M) | (6.28M) | (1.53M) | (3.85M) | (6.27M) |
| Income Before Tax | (1.61M) | 1.31M | 5.33M | 5.9M | 5.9M |
| Pre-Tax Margin | -6.5% | 3.3% | 10.1% | 8.6% | 5.4% |
| Income Tax Expense | 333.08K | 92.08K | 778.25K | 2.9M | (209.56K) |
| Net Income | (1.95M) | 1.21M | 4.55M | 3M | 6.11M |
| Net Margin | -7.9% | 3.0% | 8.7% | 4.4% | 5.6% |
| EPS (Basic) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| EPS (Diluted) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| Weighted Avg Shares | 36.4M | 41.49M | 43.65M | 49.2M | 58.54M |
| Weighted Avg Shares (Diluted) | 36.4M | 42.56M | 46.6M | 50.93M | 60.29M |
Vitalhub Corp.
TSX:VHI.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.